Two leading researchers and a former CMS official will discuss why the No Surprises Act has failed to deliver on its cost-cutting promise, what could be done to change things, and whether there are larger lessons for future policy change.
Federal Policy
Posted inCost of Care
Doctors Hated the No Surprises Act. Now Some Are Getting Rich Off of It.
Doctors are winning big paydays from insurers under a law intended to protect patients and rein in high prices.
Posted inHealth Law
How a Supreme Court Fight Over Fish Oil Could Raise Your Prescription Drug Costs
The justices are set to hear Hikma v. Amarin, a battle over drug patents that could raise costs for patients and change the way generic companies do business.
Posted inPublic Health
Trump’s Pick to Quiet the Chaos at HHS
The administration is looking to former health care executive Chris Klomp to help RFK Jr. get Trump’s health agenda back on track.
Posted inHealth Equity
Immigration Enforcement’s Twin Threats to Health Care
Patients are afraid to show up to medical appointments, while workers are being detained, deported or losing their visa statuses.
Posted inPublic Health
Inside Maryland’s High-Stakes Bid for Trump’s $50 Billion Rural Health Fund
The White House asked states to compete for a rare pot of new money dedicated to transforming health care across rural America.
Posted inPublic Health
One State’s Sprint for its Share of $50 Billion for Rural Health: Part 2
Maryland finds out how much the state will get from a nationwide competition for federal rural health investment.
Posted inHealth Equity
Breaking Down Trump’s $50 Billion Rural Health Fund
Rural health experts dig into the Trump administration’s effort to transform rural health care.
Decoding the Moment: The $50 Billion Rural Health Program in Context
All 50 states have submitted proposals to the Trump administration for a piece of the new $50 billion Rural Health Transformation Program. Passed as part of the Republicans’ megabill last […]
Posted inCost of Care
What Would Actually Lower Drug Prices in America? Experts Weigh In
Some of America’s top scholars on prescription drug pricing outline steps the Trump administration could take to make medicines more affordable.